UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 706

Sortiert nach

In Vitro Activity of APX001A (Manogepix) and Comparator Agents against 1,706 Fungal Isolates Collected during an International Surveillance Program in 2017

Antimicrobial agents and chemotherapy, 2019-08, Vol.63 (8)

2019

Volltextzugriff (PDF)

Evolving oxazolidinone resistance mechanisms in a worldwide collection of enterococcal clinical isolates: results from the SENTRY Antimicrobial Surveillance Program

Journal of antimicrobial chemotherapy, 2018-09, Vol.73 (9), p.2314-2322

2018

Volltextzugriff (PDF)

In Vitro Activity of Delafloxacin against Contemporary Bacterial Pathogens from the United States and Europe, 2014

Antimicrobial agents and chemotherapy, 2017-04, Vol.61 (4)

2017

Volltextzugriff (PDF)

In Vitro Activity of the Novel Lactone Ketolide Nafithromycin (WCK 4873) against Contemporary Clinical Bacteria from a Global Surveillance Program

Antimicrobial agents and chemotherapy, 2017-12, Vol.61 (12)

2017

Volltextzugriff (PDF)

Gepotidacin (GSK2140944) In Vitro Activity against Gram-Positive and Gram-Negative Bacteria

Antimicrobial agents and chemotherapy, 2017-07, Vol.61 (7)

2017

Volltextzugriff (PDF)

In Vitro Activity of Delafloxacin and Microbiological Response against Fluoroquinolone-Susceptible and Nonsusceptible Staphylococcus aureus Isolates from Two Phase 3 Studies of Acute Bacterial Skin and Skin Structure Infections

Antimicrobial agents and chemotherapy, 2017-09, Vol.61 (9)

2017

Volltextzugriff (PDF)

In Vitro Activity of Gepotidacin (GSK2140944) against Neisseria gonorrhoeae

Antimicrobial agents and chemotherapy, 2017-03, Vol.61 (3)

2017

Volltextzugriff (PDF)

Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in the Asia-Pacific region (minus China, Australia and New Zealand): report from an Antimicrobial Surveillance Programme (2013–2015)

International journal of antimicrobial agents, 2018-02, Vol.51 (2), p.181-189

2018

Volltextzugriff (PDF)

Activity of omadacycline tested against Streptococcus pneumoniae from a global surveillance program (2014)

Diagnostic microbiology and infectious disease, 2018-02, Vol.90 (2), p.143-147

2018

Volltextzugriff (PDF)

Antimicrobial Activity of Tigecycline and Cefoperazone/Sulbactam Tested against 18,386 Gram-negative Organisms from Europe and the Asia-Pacific Region (2013–2014)

Diagnostic microbiology and infectious disease, 2017-06, Vol.88 (2), p.177-183

2017

Volltextzugriff (PDF)

Antimicrobial activity of ceftobiprole and comparator agents when tested against contemporary Gram-positive and -negative organisms collected from Europe (2015)

Diagnostic microbiology and infectious disease, 2018-05, Vol.91 (1), p.77-84

2018

Volltextzugriff (PDF)

Erratum for Pfaller et al., " In Vitro Activity of Delafloxacin against Contemporary Bacterial Pathogens from the United States and Europe, 2014"

Antimicrobial agents and chemotherapy, 2018-02, Vol.62 (2)

2018

Volltextzugriff (PDF)

Oritavancin in vitro activity against gram-positive organisms from European and United States medical centers: results from the SENTRY Antimicrobial Surveillance Program for 2010–2014

Diagnostic microbiology and infectious disease, 2018-06, Vol.91 (2), p.199-204

2018

Volltextzugriff (PDF)

Activity of omadacycline tested against Enterobacteriaceae causing urinary tract infections from a global surveillance program (2014)

Diagnostic microbiology and infectious disease, 2018-06, Vol.91 (2), p.179-183

2018

Volltextzugriff (PDF)

Delafloxacin In Vitro Broth Microdilution and Disk Diffusion Antimicrobial Susceptibility Testing Guidelines: Susceptibility Breakpoint Criteria and Quality Control Ranges for an Expanded-Spectrum Anionic Fluoroquinolone

Journal of clinical microbiology, 2018-08, Vol.56 (8)

2018

Volltextzugriff (PDF)

Update of the activity of telavancin against a global collection of Staphylococcus aureus causing bacteremia, including endocarditis (2011–2014)

European journal of clinical microbiology & infectious diseases, 2017-06, Vol.36 (6), p.1013-1017

2017

Volltextzugriff (PDF)

Comparison of Broth Microdilution, Agar Dilution, and Etest for Susceptibility Testing of Doripenem against Gram-Negative and Gram-Positive Pathogens

Journal of Clinical Microbiology, 2010-09, Vol.48 (9), p.3353-3357

2010

Volltextzugriff (PDF)

Prevalence of Macrolide Resistance Mechanisms in Streptococcus pneumoniae Isolates from a Multicenter Antibiotic Resistance Surveillance Study Conducted in the United States in 1994–1995

Clinical infectious diseases, 1999-11, Vol.29 (5), p.1186-1188

1999

Volltextzugriff (PDF)

Challenges in systematic reviews of diagnostic technologies

Annals of internal medicine, 2005-06, Vol.142 (12 Pt 2), p.1048

2005

Volltextzugriff (PDF)

Ceftolozane–tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in Australia and New Zealand: Report from an Antimicrobial Surveillance Program (2013–2015)

Journal of global antimicrobial resistance., 2017-09, Vol.10, p.186-194

2017

Volltextzugriff (PDF)

Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori

Antimicrobial Agents and Chemotherapy, 1996-02, Vol.40 (2), p.477-480

1996

Volltextzugriff (PDF)

Design, Synthesis, and Antimicrobial Activity of 6-O-Substituted Ketolides Active against Resistant Respiratory Tract Pathogens

Journal of medicinal chemistry, 2000-03, Vol.43 (6), p.1045-1049

2000

Volltextzugriff (PDF)

In Vitro Antibacterial Potency and Spectrum of ABT-492, a New Fluoroquinolone

Antimicrobial Agents and Chemotherapy, 2003-10, Vol.47 (10), p.3260-3269

2003

Volltextzugriff (PDF)

Comparative In Vitro Activity of ABT-773, a Novel Antibacterial Ketolide

Antimicrobial Agents and Chemotherapy, 2001-07, Vol.45 (7), p.2163-2168

2001

Volltextzugriff (PDF)

Novel Erythromycin Derivatives with Aryl Groups Tethered to the C-6 Position Are Potent Protein Synthesis Inhibitors and Active against Multidrug-Resistant Respiratory Pathogens

Journal of medicinal chemistry, 2001-11, Vol.44 (24), p.4137-4156

2001

Volltextzugriff (PDF)

1 – 25 von 706

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(622)
Mit Volltextzugriff
(636)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(690)
Japanisch
(76)
Deutsch
(15)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(418)
Life Sciences & Biomedicine
(374)
Humans
(286)
Biological And Medical Sciences
(189)
Medical Sciences
(152)
Female
(134)
Male
(129)
Microbiology
(120)
Adult
(102)
Middle Aged
(101)
Infectious Diseases
(91)
Pharmacology & Pharmacy
(86)
Anti-Bacterial Agents - Pharmacology
(79)
Aged
(71)
Microbial Sensitivity Tests
(62)
Cardiovascular System & Cardiology
(55)
Animals
(51)
Pharmacology. Drug Treatments
(51)
Cardiac & Cardiovascular Systems
(48)
Fundamental And Applied Biological Sciences. Psychology
(45)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

In Vitro Activity of APX001A (Manogepix) and Comparator Agents against 1,706 Fungal Isolates Collected during an International Surveillance Program in 2017

Evolving oxazolidinone resistance mechanisms in a worldwide collection of enterococcal clinical isolates: results from the SENTRY Antimicrobial Surveillance Program

In Vitro Activity of Delafloxacin against Contemporary Bacterial Pathogens from the United States and Europe, 2014

In Vitro Activity of the Novel Lactone Ketolide Nafithromycin (WCK 4873) against Contemporary Clinical Bacteria from a Global Surveillance Program

Gepotidacin (GSK2140944) In Vitro Activity against Gram-Positive and Gram-Negative Bacteria

In Vitro Activity of Delafloxacin and Microbiological Response against Fluoroquinolone-Susceptible and Nonsusceptible Staphylococcus aureus Isolates from Two Phase 3 Studies of Acute Bacterial Skin and Skin Structure Infections

In Vitro Activity of Gepotidacin (GSK2140944) against Neisseria gonorrhoeae

Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in the Asia-Pacific region (minus China, Australia and New Zealand): report from an Antimicrobial Surveillance Programme (2013–2015)

Activity of omadacycline tested against Streptococcus pneumoniae from a global surveillance program (2014)

Antimicrobial Activity of Tigecycline and Cefoperazone/Sulbactam Tested against 18,386 Gram-negative Organisms from Europe and the Asia-Pacific Region (2013–2014)

Antimicrobial activity of ceftobiprole and comparator agents when tested against contemporary Gram-positive and -negative organisms collected from Europe (2015)

Erratum for Pfaller et al., " In Vitro Activity of Delafloxacin against Contemporary Bacterial Pathogens from the United States and Europe, 2014"

Oritavancin in vitro activity against gram-positive organisms from European and United States medical centers: results from the SENTRY Antimicrobial Surveillance Program for 2010–2014

Activity of omadacycline tested against Enterobacteriaceae causing urinary tract infections from a global surveillance program (2014)

Delafloxacin In Vitro Broth Microdilution and Disk Diffusion Antimicrobial Susceptibility Testing Guidelines: Susceptibility Breakpoint Criteria and Quality Control Ranges for an Expanded-Spectrum Anionic Fluoroquinolone

Update of the activity of telavancin against a global collection of Staphylococcus aureus causing bacteremia, including endocarditis (2011–2014)

Comparison of Broth Microdilution, Agar Dilution, and Etest for Susceptibility Testing of Doripenem against Gram-Negative and Gram-Positive Pathogens

Prevalence of Macrolide Resistance Mechanisms in Streptococcus pneumoniae Isolates from a Multicenter Antibiotic Resistance Surveillance Study Conducted in the United States in 1994–1995

Challenges in systematic reviews of diagnostic technologies

Ceftolozane–tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in Australia and New Zealand: Report from an Antimicrobial Surveillance Program (2013–2015)

Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori

Design, Synthesis, and Antimicrobial Activity of 6-O-Substituted Ketolides Active against Resistant Respiratory Tract Pathogens

In Vitro Antibacterial Potency and Spectrum of ABT-492, a New Fluoroquinolone

Comparative In Vitro Activity of ABT-773, a Novel Antibacterial Ketolide

Novel Erythromycin Derivatives with Aryl Groups Tethered to the C-6 Position Are Potent Protein Synthesis Inhibitors and Active against Multidrug-Resistant Respiratory Pathogens

Suchergebnisse filtern